Global Inhaler Devices Market
Global Inhaler Devices Market

Inhaler Devices Comprehensive Study by Type (Pressurized Metered Dose Inhaler (pMDI), Dry Powder Inhaler (DPI), Soft Mist Inhaler (SMI)), Application (Residential, Hospital, Clinic, Respiratory Care Centers), Sales Channel (Online, Offline), End User (Adults, Children) Players and Region - Global Market Outlook to 2027

Inhaler Devices Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Feb 2022 Edition 219 Pages 195 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Inhaler Devices?
Inhaler devices are used to deliver medicines for asthma which delivers medicines to the lungs and airways. The inhaler devices are available in shapes & sizes prescribed by doctors or asthma educators. It is mainly used to prevent diseases of the respiratory airways like chronic obstructive pulmonary diseases or cystic fibrosis. The device is available in three types such as pressurized metered-dose inhalers, dry powder inhalers, and soft mist inhalers.

The market study is broken down by Type (Pressurized Metered Dose Inhaler (pMDI), Dry Powder Inhaler (DPI) and Soft Mist Inhaler (SMI)), by Application (Residential, Hospital, Clinic and Respiratory Care Centers) and major geographies with country level break-up.

Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

3M (United States), Gerresheimer AG (Germany), Boehringer Ingelheim International GmbH (Germany), Cipla Limited (India), Cohero Health, Inc (United States), Iconovo AB (Sweden), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline (United Kingdom), MannKind Corporation (United States) and Beximco Pharmaceuticals Ltd (Bangladesh) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Inhaler Devices market by Type, Application and Region.

On the basis of geography, the market of Inhaler Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channel, the sub-segment i.e. Online will boost the Inhaler Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Adults will boost the Inhaler Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On 21st September 2020, Teva Launches Two Digital Inhalers in the U.S., AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder, and ArmonAir Digihaler (fluticasone propionate) Inhalation Powder. AirDuo Digihaler is a prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in people 12 years of age and older.
On 5th August 2019, MannKind Corporation and One Drop today announced that they have signed a collaborative agreement that is intended to integrate MannKindís BluHale accessory device into the One Drop platform. BluHale is a Bluetooth-connected accessory that attaches to the Afrezza inhaler and is designed to convey real-time information about inhalation effort and insulin dose.
"It is important to note that Metered Dose Inhalers and Actuators are reviewed in the Center for Drug Evaluation and Research (CDER), where Nebulizers and Spacers, as well as Metered Dose Inhalers intended for a ventilator circuit, are reviewed in the Center for Devices and Radiological Health (CDRH). Since there are a variety of medical products in the category of nebulizers and MDIS, it is not possible to develop an exhaustive guidance document that will cover all modalities in most applications. However, the general principles regarding the information to be contained in a 510(k) should be valid for all cases."

Market Trend
  • Increasing Consumption of Metered Dose Inhaler Devices in Different Sizes and Shapes

Market Drivers
  • Growing Number of Patients with the Respiratory Airway Disease
  • Need for the Portable and Compact Inhaling Devices

Opportunities
  • Technological Advancements in the Inhaling Devices
  • Rising Availability of Inhaler Devices in E-commerce Sites

Restraints
  • Materials Used in the Production and Packaging of Inhaling Devices Affecting the Environment

Challenges
  • Stiff Competition in the Inhaling Devices Market


Key Target Audience
Inhaler Devices Manufacturers, Inhaler Devices International Traders, Inhaler Devices Distributors & Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as 3M (United States), Gerresheimer AG (Germany), Boehringer Ingelheim International GmbH (Germany), Cipla Limited (India), Cohero Health, Inc (United States), Iconovo AB (Sweden), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline (United Kingdom), MannKind Corporation (United States) and Beximco Pharmaceuticals Ltd (Bangladesh) etc.

2. Can we have customized study for Inhaler Devices Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Inhaler Devices Market by 2027?
Analysts at AMA estimates Inhaler Devices Market to reach USD Million by 2027.
Report Objectives / Segmentation Covered
By Type
  • Pressurized Metered Dose Inhaler (pMDI)
  • Dry Powder Inhaler (DPI)
  • Soft Mist Inhaler (SMI)
By Application
  • Residential
  • Hospital
  • Clinic
  • Respiratory Care Centers
By Sales Channel
  • Online
  • Offline

By End User
  • Adults
  • Children

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Patients with the Respiratory Airway Disease
      • 3.2.2. Need for the Portable and Compact Inhaling Devices
    • 3.3. Market Challenges
      • 3.3.1. Stiff Competition in the Inhaling Devices Market
    • 3.4. Market Trends
      • 3.4.1. Increasing Consumption of Metered Dose Inhaler Devices in Different Sizes and Shapes
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Inhaler Devices, by Type, Application, Sales Channel, End User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Inhaler Devices (Value)
      • 5.2.1. Global Inhaler Devices by: Type (Value)
        • 5.2.1.1. Pressurized Metered Dose Inhaler (pMDI)
        • 5.2.1.2. Dry Powder Inhaler (DPI)
        • 5.2.1.3. Soft Mist Inhaler (SMI)
      • 5.2.2. Global Inhaler Devices by: Application (Value)
        • 5.2.2.1. Residential
        • 5.2.2.2. Hospital
        • 5.2.2.3. Clinic
        • 5.2.2.4. Respiratory Care Centers
      • 5.2.3. Global Inhaler Devices by: Sales Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Inhaler Devices by: End User (Value)
        • 5.2.4.1. Adults
        • 5.2.4.2. Children
      • 5.2.5. Global Inhaler Devices Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Inhaler Devices (Price)
      • 5.3.1. Global Inhaler Devices by: Type (Price)
  • 6. Inhaler Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Gerresheimer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cipla Limited (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cohero Health, Inc (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Iconovo AB (Sweden)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GlaxoSmithKline (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. MannKind Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Beximco Pharmaceuticals Ltd (Bangladesh)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Inhaler Devices Sale, by Type, Application, Sales Channel, End User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Inhaler Devices (Value)
      • 7.2.1. Global Inhaler Devices by: Type (Value)
        • 7.2.1.1. Pressurized Metered Dose Inhaler (pMDI)
        • 7.2.1.2. Dry Powder Inhaler (DPI)
        • 7.2.1.3. Soft Mist Inhaler (SMI)
      • 7.2.2. Global Inhaler Devices by: Application (Value)
        • 7.2.2.1. Residential
        • 7.2.2.2. Hospital
        • 7.2.2.3. Clinic
        • 7.2.2.4. Respiratory Care Centers
      • 7.2.3. Global Inhaler Devices by: Sales Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Inhaler Devices by: End User (Value)
        • 7.2.4.1. Adults
        • 7.2.4.2. Children
      • 7.2.5. Global Inhaler Devices Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Inhaler Devices (Price)
      • 7.3.1. Global Inhaler Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Inhaler Devices: by Type(USD Million)
  • Table 2. Inhaler Devices Pressurized Metered Dose Inhaler (pMDI) , by Region USD Million (2016-2021)
  • Table 3. Inhaler Devices Dry Powder Inhaler (DPI) , by Region USD Million (2016-2021)
  • Table 4. Inhaler Devices Soft Mist Inhaler (SMI) , by Region USD Million (2016-2021)
  • Table 5. Inhaler Devices: by Application(USD Million)
  • Table 6. Inhaler Devices Residential , by Region USD Million (2016-2021)
  • Table 7. Inhaler Devices Hospital , by Region USD Million (2016-2021)
  • Table 8. Inhaler Devices Clinic , by Region USD Million (2016-2021)
  • Table 9. Inhaler Devices Respiratory Care Centers , by Region USD Million (2016-2021)
  • Table 10. Inhaler Devices: by Sales Channel(USD Million)
  • Table 11. Inhaler Devices Online , by Region USD Million (2016-2021)
  • Table 12. Inhaler Devices Offline , by Region USD Million (2016-2021)
  • Table 13. Inhaler Devices: by End User(USD Million)
  • Table 14. Inhaler Devices Adults , by Region USD Million (2016-2021)
  • Table 15. Inhaler Devices Children , by Region USD Million (2016-2021)
  • Table 16. South America Inhaler Devices, by Country USD Million (2016-2021)
  • Table 17. South America Inhaler Devices, by Type USD Million (2016-2021)
  • Table 18. South America Inhaler Devices, by Application USD Million (2016-2021)
  • Table 19. South America Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 20. South America Inhaler Devices, by End User USD Million (2016-2021)
  • Table 21. Brazil Inhaler Devices, by Type USD Million (2016-2021)
  • Table 22. Brazil Inhaler Devices, by Application USD Million (2016-2021)
  • Table 23. Brazil Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 24. Brazil Inhaler Devices, by End User USD Million (2016-2021)
  • Table 25. Argentina Inhaler Devices, by Type USD Million (2016-2021)
  • Table 26. Argentina Inhaler Devices, by Application USD Million (2016-2021)
  • Table 27. Argentina Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 28. Argentina Inhaler Devices, by End User USD Million (2016-2021)
  • Table 29. Rest of South America Inhaler Devices, by Type USD Million (2016-2021)
  • Table 30. Rest of South America Inhaler Devices, by Application USD Million (2016-2021)
  • Table 31. Rest of South America Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 32. Rest of South America Inhaler Devices, by End User USD Million (2016-2021)
  • Table 33. Asia Pacific Inhaler Devices, by Country USD Million (2016-2021)
  • Table 34. Asia Pacific Inhaler Devices, by Type USD Million (2016-2021)
  • Table 35. Asia Pacific Inhaler Devices, by Application USD Million (2016-2021)
  • Table 36. Asia Pacific Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 37. Asia Pacific Inhaler Devices, by End User USD Million (2016-2021)
  • Table 38. China Inhaler Devices, by Type USD Million (2016-2021)
  • Table 39. China Inhaler Devices, by Application USD Million (2016-2021)
  • Table 40. China Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 41. China Inhaler Devices, by End User USD Million (2016-2021)
  • Table 42. Japan Inhaler Devices, by Type USD Million (2016-2021)
  • Table 43. Japan Inhaler Devices, by Application USD Million (2016-2021)
  • Table 44. Japan Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 45. Japan Inhaler Devices, by End User USD Million (2016-2021)
  • Table 46. India Inhaler Devices, by Type USD Million (2016-2021)
  • Table 47. India Inhaler Devices, by Application USD Million (2016-2021)
  • Table 48. India Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 49. India Inhaler Devices, by End User USD Million (2016-2021)
  • Table 50. South Korea Inhaler Devices, by Type USD Million (2016-2021)
  • Table 51. South Korea Inhaler Devices, by Application USD Million (2016-2021)
  • Table 52. South Korea Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 53. South Korea Inhaler Devices, by End User USD Million (2016-2021)
  • Table 54. Taiwan Inhaler Devices, by Type USD Million (2016-2021)
  • Table 55. Taiwan Inhaler Devices, by Application USD Million (2016-2021)
  • Table 56. Taiwan Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 57. Taiwan Inhaler Devices, by End User USD Million (2016-2021)
  • Table 58. Australia Inhaler Devices, by Type USD Million (2016-2021)
  • Table 59. Australia Inhaler Devices, by Application USD Million (2016-2021)
  • Table 60. Australia Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 61. Australia Inhaler Devices, by End User USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Inhaler Devices, by Type USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Inhaler Devices, by Application USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Inhaler Devices, by End User USD Million (2016-2021)
  • Table 66. Europe Inhaler Devices, by Country USD Million (2016-2021)
  • Table 67. Europe Inhaler Devices, by Type USD Million (2016-2021)
  • Table 68. Europe Inhaler Devices, by Application USD Million (2016-2021)
  • Table 69. Europe Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 70. Europe Inhaler Devices, by End User USD Million (2016-2021)
  • Table 71. Germany Inhaler Devices, by Type USD Million (2016-2021)
  • Table 72. Germany Inhaler Devices, by Application USD Million (2016-2021)
  • Table 73. Germany Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 74. Germany Inhaler Devices, by End User USD Million (2016-2021)
  • Table 75. France Inhaler Devices, by Type USD Million (2016-2021)
  • Table 76. France Inhaler Devices, by Application USD Million (2016-2021)
  • Table 77. France Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 78. France Inhaler Devices, by End User USD Million (2016-2021)
  • Table 79. Italy Inhaler Devices, by Type USD Million (2016-2021)
  • Table 80. Italy Inhaler Devices, by Application USD Million (2016-2021)
  • Table 81. Italy Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 82. Italy Inhaler Devices, by End User USD Million (2016-2021)
  • Table 83. United Kingdom Inhaler Devices, by Type USD Million (2016-2021)
  • Table 84. United Kingdom Inhaler Devices, by Application USD Million (2016-2021)
  • Table 85. United Kingdom Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 86. United Kingdom Inhaler Devices, by End User USD Million (2016-2021)
  • Table 87. Netherlands Inhaler Devices, by Type USD Million (2016-2021)
  • Table 88. Netherlands Inhaler Devices, by Application USD Million (2016-2021)
  • Table 89. Netherlands Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 90. Netherlands Inhaler Devices, by End User USD Million (2016-2021)
  • Table 91. Rest of Europe Inhaler Devices, by Type USD Million (2016-2021)
  • Table 92. Rest of Europe Inhaler Devices, by Application USD Million (2016-2021)
  • Table 93. Rest of Europe Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 94. Rest of Europe Inhaler Devices, by End User USD Million (2016-2021)
  • Table 95. MEA Inhaler Devices, by Country USD Million (2016-2021)
  • Table 96. MEA Inhaler Devices, by Type USD Million (2016-2021)
  • Table 97. MEA Inhaler Devices, by Application USD Million (2016-2021)
  • Table 98. MEA Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 99. MEA Inhaler Devices, by End User USD Million (2016-2021)
  • Table 100. Middle East Inhaler Devices, by Type USD Million (2016-2021)
  • Table 101. Middle East Inhaler Devices, by Application USD Million (2016-2021)
  • Table 102. Middle East Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 103. Middle East Inhaler Devices, by End User USD Million (2016-2021)
  • Table 104. Africa Inhaler Devices, by Type USD Million (2016-2021)
  • Table 105. Africa Inhaler Devices, by Application USD Million (2016-2021)
  • Table 106. Africa Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 107. Africa Inhaler Devices, by End User USD Million (2016-2021)
  • Table 108. North America Inhaler Devices, by Country USD Million (2016-2021)
  • Table 109. North America Inhaler Devices, by Type USD Million (2016-2021)
  • Table 110. North America Inhaler Devices, by Application USD Million (2016-2021)
  • Table 111. North America Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 112. North America Inhaler Devices, by End User USD Million (2016-2021)
  • Table 113. United States Inhaler Devices, by Type USD Million (2016-2021)
  • Table 114. United States Inhaler Devices, by Application USD Million (2016-2021)
  • Table 115. United States Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 116. United States Inhaler Devices, by End User USD Million (2016-2021)
  • Table 117. Canada Inhaler Devices, by Type USD Million (2016-2021)
  • Table 118. Canada Inhaler Devices, by Application USD Million (2016-2021)
  • Table 119. Canada Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 120. Canada Inhaler Devices, by End User USD Million (2016-2021)
  • Table 121. Mexico Inhaler Devices, by Type USD Million (2016-2021)
  • Table 122. Mexico Inhaler Devices, by Application USD Million (2016-2021)
  • Table 123. Mexico Inhaler Devices, by Sales Channel USD Million (2016-2021)
  • Table 124. Mexico Inhaler Devices, by End User USD Million (2016-2021)
  • Table 125. Inhaler Devices: by Type(USD/Units)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Inhaler Devices: by Type(USD Million)
  • Table 137. Inhaler Devices Pressurized Metered Dose Inhaler (pMDI) , by Region USD Million (2022-2027)
  • Table 138. Inhaler Devices Dry Powder Inhaler (DPI) , by Region USD Million (2022-2027)
  • Table 139. Inhaler Devices Soft Mist Inhaler (SMI) , by Region USD Million (2022-2027)
  • Table 140. Inhaler Devices: by Application(USD Million)
  • Table 141. Inhaler Devices Residential , by Region USD Million (2022-2027)
  • Table 142. Inhaler Devices Hospital , by Region USD Million (2022-2027)
  • Table 143. Inhaler Devices Clinic , by Region USD Million (2022-2027)
  • Table 144. Inhaler Devices Respiratory Care Centers , by Region USD Million (2022-2027)
  • Table 145. Inhaler Devices: by Sales Channel(USD Million)
  • Table 146. Inhaler Devices Online , by Region USD Million (2022-2027)
  • Table 147. Inhaler Devices Offline , by Region USD Million (2022-2027)
  • Table 148. Inhaler Devices: by End User(USD Million)
  • Table 149. Inhaler Devices Adults , by Region USD Million (2022-2027)
  • Table 150. Inhaler Devices Children , by Region USD Million (2022-2027)
  • Table 151. South America Inhaler Devices, by Country USD Million (2022-2027)
  • Table 152. South America Inhaler Devices, by Type USD Million (2022-2027)
  • Table 153. South America Inhaler Devices, by Application USD Million (2022-2027)
  • Table 154. South America Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 155. South America Inhaler Devices, by End User USD Million (2022-2027)
  • Table 156. Brazil Inhaler Devices, by Type USD Million (2022-2027)
  • Table 157. Brazil Inhaler Devices, by Application USD Million (2022-2027)
  • Table 158. Brazil Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 159. Brazil Inhaler Devices, by End User USD Million (2022-2027)
  • Table 160. Argentina Inhaler Devices, by Type USD Million (2022-2027)
  • Table 161. Argentina Inhaler Devices, by Application USD Million (2022-2027)
  • Table 162. Argentina Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 163. Argentina Inhaler Devices, by End User USD Million (2022-2027)
  • Table 164. Rest of South America Inhaler Devices, by Type USD Million (2022-2027)
  • Table 165. Rest of South America Inhaler Devices, by Application USD Million (2022-2027)
  • Table 166. Rest of South America Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 167. Rest of South America Inhaler Devices, by End User USD Million (2022-2027)
  • Table 168. Asia Pacific Inhaler Devices, by Country USD Million (2022-2027)
  • Table 169. Asia Pacific Inhaler Devices, by Type USD Million (2022-2027)
  • Table 170. Asia Pacific Inhaler Devices, by Application USD Million (2022-2027)
  • Table 171. Asia Pacific Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 172. Asia Pacific Inhaler Devices, by End User USD Million (2022-2027)
  • Table 173. China Inhaler Devices, by Type USD Million (2022-2027)
  • Table 174. China Inhaler Devices, by Application USD Million (2022-2027)
  • Table 175. China Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 176. China Inhaler Devices, by End User USD Million (2022-2027)
  • Table 177. Japan Inhaler Devices, by Type USD Million (2022-2027)
  • Table 178. Japan Inhaler Devices, by Application USD Million (2022-2027)
  • Table 179. Japan Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 180. Japan Inhaler Devices, by End User USD Million (2022-2027)
  • Table 181. India Inhaler Devices, by Type USD Million (2022-2027)
  • Table 182. India Inhaler Devices, by Application USD Million (2022-2027)
  • Table 183. India Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 184. India Inhaler Devices, by End User USD Million (2022-2027)
  • Table 185. South Korea Inhaler Devices, by Type USD Million (2022-2027)
  • Table 186. South Korea Inhaler Devices, by Application USD Million (2022-2027)
  • Table 187. South Korea Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 188. South Korea Inhaler Devices, by End User USD Million (2022-2027)
  • Table 189. Taiwan Inhaler Devices, by Type USD Million (2022-2027)
  • Table 190. Taiwan Inhaler Devices, by Application USD Million (2022-2027)
  • Table 191. Taiwan Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 192. Taiwan Inhaler Devices, by End User USD Million (2022-2027)
  • Table 193. Australia Inhaler Devices, by Type USD Million (2022-2027)
  • Table 194. Australia Inhaler Devices, by Application USD Million (2022-2027)
  • Table 195. Australia Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 196. Australia Inhaler Devices, by End User USD Million (2022-2027)
  • Table 197. Rest of Asia-Pacific Inhaler Devices, by Type USD Million (2022-2027)
  • Table 198. Rest of Asia-Pacific Inhaler Devices, by Application USD Million (2022-2027)
  • Table 199. Rest of Asia-Pacific Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 200. Rest of Asia-Pacific Inhaler Devices, by End User USD Million (2022-2027)
  • Table 201. Europe Inhaler Devices, by Country USD Million (2022-2027)
  • Table 202. Europe Inhaler Devices, by Type USD Million (2022-2027)
  • Table 203. Europe Inhaler Devices, by Application USD Million (2022-2027)
  • Table 204. Europe Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 205. Europe Inhaler Devices, by End User USD Million (2022-2027)
  • Table 206. Germany Inhaler Devices, by Type USD Million (2022-2027)
  • Table 207. Germany Inhaler Devices, by Application USD Million (2022-2027)
  • Table 208. Germany Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 209. Germany Inhaler Devices, by End User USD Million (2022-2027)
  • Table 210. France Inhaler Devices, by Type USD Million (2022-2027)
  • Table 211. France Inhaler Devices, by Application USD Million (2022-2027)
  • Table 212. France Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 213. France Inhaler Devices, by End User USD Million (2022-2027)
  • Table 214. Italy Inhaler Devices, by Type USD Million (2022-2027)
  • Table 215. Italy Inhaler Devices, by Application USD Million (2022-2027)
  • Table 216. Italy Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 217. Italy Inhaler Devices, by End User USD Million (2022-2027)
  • Table 218. United Kingdom Inhaler Devices, by Type USD Million (2022-2027)
  • Table 219. United Kingdom Inhaler Devices, by Application USD Million (2022-2027)
  • Table 220. United Kingdom Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 221. United Kingdom Inhaler Devices, by End User USD Million (2022-2027)
  • Table 222. Netherlands Inhaler Devices, by Type USD Million (2022-2027)
  • Table 223. Netherlands Inhaler Devices, by Application USD Million (2022-2027)
  • Table 224. Netherlands Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 225. Netherlands Inhaler Devices, by End User USD Million (2022-2027)
  • Table 226. Rest of Europe Inhaler Devices, by Type USD Million (2022-2027)
  • Table 227. Rest of Europe Inhaler Devices, by Application USD Million (2022-2027)
  • Table 228. Rest of Europe Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 229. Rest of Europe Inhaler Devices, by End User USD Million (2022-2027)
  • Table 230. MEA Inhaler Devices, by Country USD Million (2022-2027)
  • Table 231. MEA Inhaler Devices, by Type USD Million (2022-2027)
  • Table 232. MEA Inhaler Devices, by Application USD Million (2022-2027)
  • Table 233. MEA Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 234. MEA Inhaler Devices, by End User USD Million (2022-2027)
  • Table 235. Middle East Inhaler Devices, by Type USD Million (2022-2027)
  • Table 236. Middle East Inhaler Devices, by Application USD Million (2022-2027)
  • Table 237. Middle East Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 238. Middle East Inhaler Devices, by End User USD Million (2022-2027)
  • Table 239. Africa Inhaler Devices, by Type USD Million (2022-2027)
  • Table 240. Africa Inhaler Devices, by Application USD Million (2022-2027)
  • Table 241. Africa Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 242. Africa Inhaler Devices, by End User USD Million (2022-2027)
  • Table 243. North America Inhaler Devices, by Country USD Million (2022-2027)
  • Table 244. North America Inhaler Devices, by Type USD Million (2022-2027)
  • Table 245. North America Inhaler Devices, by Application USD Million (2022-2027)
  • Table 246. North America Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 247. North America Inhaler Devices, by End User USD Million (2022-2027)
  • Table 248. United States Inhaler Devices, by Type USD Million (2022-2027)
  • Table 249. United States Inhaler Devices, by Application USD Million (2022-2027)
  • Table 250. United States Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 251. United States Inhaler Devices, by End User USD Million (2022-2027)
  • Table 252. Canada Inhaler Devices, by Type USD Million (2022-2027)
  • Table 253. Canada Inhaler Devices, by Application USD Million (2022-2027)
  • Table 254. Canada Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 255. Canada Inhaler Devices, by End User USD Million (2022-2027)
  • Table 256. Mexico Inhaler Devices, by Type USD Million (2022-2027)
  • Table 257. Mexico Inhaler Devices, by Application USD Million (2022-2027)
  • Table 258. Mexico Inhaler Devices, by Sales Channel USD Million (2022-2027)
  • Table 259. Mexico Inhaler Devices, by End User USD Million (2022-2027)
  • Table 260. Inhaler Devices: by Type(USD/Units)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Inhaler Devices: by Type USD Million (2016-2021)
  • Figure 5. Global Inhaler Devices: by Application USD Million (2016-2021)
  • Figure 6. Global Inhaler Devices: by Sales Channel USD Million (2016-2021)
  • Figure 7. Global Inhaler Devices: by End User USD Million (2016-2021)
  • Figure 8. South America Inhaler Devices Share (%), by Country
  • Figure 9. Asia Pacific Inhaler Devices Share (%), by Country
  • Figure 10. Europe Inhaler Devices Share (%), by Country
  • Figure 11. MEA Inhaler Devices Share (%), by Country
  • Figure 12. North America Inhaler Devices Share (%), by Country
  • Figure 13. Global Inhaler Devices: by Type USD/Units (2016-2021)
  • Figure 14. Global Inhaler Devices share by Players 2021 (%)
  • Figure 15. Global Inhaler Devices share by Players (Top 3) 2021(%)
  • Figure 16. Global Inhaler Devices share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 19. 3M (United States) Revenue: by Geography 2021
  • Figure 20. Gerresheimer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Gerresheimer AG (Germany) Revenue: by Geography 2021
  • Figure 22. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2021
  • Figure 24. Cipla Limited (India) Revenue, Net Income and Gross profit
  • Figure 25. Cipla Limited (India) Revenue: by Geography 2021
  • Figure 26. Cohero Health, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 27. Cohero Health, Inc (United States) Revenue: by Geography 2021
  • Figure 28. Iconovo AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 29. Iconovo AB (Sweden) Revenue: by Geography 2021
  • Figure 30. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 31. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2021
  • Figure 32. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2021
  • Figure 34. MannKind Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 35. MannKind Corporation (United States) Revenue: by Geography 2021
  • Figure 36. Beximco Pharmaceuticals Ltd (Bangladesh) Revenue, Net Income and Gross profit
  • Figure 37. Beximco Pharmaceuticals Ltd (Bangladesh) Revenue: by Geography 2021
  • Figure 38. Global Inhaler Devices: by Type USD Million (2022-2027)
  • Figure 39. Global Inhaler Devices: by Application USD Million (2022-2027)
  • Figure 40. Global Inhaler Devices: by Sales Channel USD Million (2022-2027)
  • Figure 41. Global Inhaler Devices: by End User USD Million (2022-2027)
  • Figure 42. South America Inhaler Devices Share (%), by Country
  • Figure 43. Asia Pacific Inhaler Devices Share (%), by Country
  • Figure 44. Europe Inhaler Devices Share (%), by Country
  • Figure 45. MEA Inhaler Devices Share (%), by Country
  • Figure 46. North America Inhaler Devices Share (%), by Country
  • Figure 47. Global Inhaler Devices: by Type USD/Units (2022-2027)
Some of the key companies/manufacturers profiled in the report
  • 3M (United States)
  • Gerresheimer AG (Germany)
  • Boehringer Ingelheim International GmbH (Germany)
  • Cipla Limited (India)
  • Cohero Health, Inc (United States)
  • Iconovo AB (Sweden)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • GlaxoSmithKline (United Kingdom)
  • MannKind Corporation (United States)
  • Beximco Pharmaceuticals Ltd (Bangladesh)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation